- Home
- ANTE vs NLSP Comparison
ANTE vs NLSP Comparison
Compare ANTE & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- NLSP
- Stock Information
- Founded
- ANTE 2005
- NLSP 2015
- Country
- ANTE China
- NLSP Switzerland
- Employees
- ANTE N/A
- NLSP N/A
- Industry
- ANTE Advertising
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- NLSP Health Care
- Exchange
- ANTE Nasdaq
- NLSP Nasdaq
- Market Cap
- ANTE 6.2M
- NLSP 6.9M
- IPO Year
- ANTE N/A
- NLSP 2021
- Fundamental
- Price
- ANTE $0.43
- NLSP $1.47
- Analyst Decision
- ANTE
- NLSP
- Analyst Count
- ANTE 0
- NLSP 0
- Target Price
- ANTE N/A
- NLSP N/A
- AVG Volume (30 Days)
- ANTE 7.1M
- NLSP 31.2K
- Earning Date
- ANTE 05-16-2025
- NLSP 05-14-2025
- Dividend Yield
- ANTE N/A
- NLSP N/A
- EPS Growth
- ANTE N/A
- NLSP N/A
- EPS
- ANTE 2.64
- NLSP N/A
- Revenue
- ANTE $500,000.00
- NLSP N/A
- Revenue This Year
- ANTE N/A
- NLSP N/A
- Revenue Next Year
- ANTE N/A
- NLSP N/A
- P/E Ratio
- ANTE $0.16
- NLSP N/A
- Revenue Growth
- ANTE N/A
- NLSP N/A
- 52 Week Low
- ANTE $0.26
- NLSP $1.30
- 52 Week High
- ANTE $2.90
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- ANTE 45.32
- NLSP 43.01
- Support Level
- ANTE $0.38
- NLSP $1.30
- Resistance Level
- ANTE $0.50
- NLSP $1.60
- Average True Range (ATR)
- ANTE 0.16
- NLSP 0.10
- MACD
- ANTE -0.02
- NLSP 0.02
- Stochastic Oscillator
- ANTE 1.44
- NLSP 57.14
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.